Etoposide Phosphate for Injection
Indication
This product is suitable for the treatment of the following tumors: 1. Refractory testicular tumors - patients with refractory testicular tumors after appropriate surgery, chemotherapy and radiotherapy can be treated with this product in combination with other approved chemotherapy drugs; 2. Small cell lung cancer - injection of etoposide phosphate combined with other approved chemotherapy drugs as the first-line drug for patients with small cell lung cancer.
Precautions
1. Patients with a history of allergy to etoposide phosphate, etoposide and any of the components of this product are contraindicated; 2. Children, pregnant women and lactating women should use it with caution.
Special Population Medication
Precautions for children: Use with caution in children. Precautions for pregnancy and lactation: Use with caution in pregnant and lactating women.
Packaging Specification
0.1g (based on C29H32013)
Manufacturer
Chongqing Huapont Pharmaceutical Co., Ltd.
-
Founded in:
2012-06-26 -
Address:
No. 69, Renhe Xingguang Avenue, Yubei District, Chongqing -
Tax NO.:
915000005992299001 -
Registered Funds:
450 million yuan -
Website:
-
Email: